Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 1
2017 1
2019 3
2020 4
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab- and ustekinumab-treated patients with inflammatory bowel disease-a prospective multicentre cohort study.
Asscher VER, Biemans VBC, Pierik MJ, Dijkstra G, Löwenberg M, van der Marel S, de Boer NKH, Bodelier AGL, Jansen JM, West RL, Haans JJL, van Dop WA, Weersma RK, Hoentjen F, Maljaars PWJ; Dutch Initiative on Crohn and Colitis (ICC). Asscher VER, et al. Among authors: maljaars pwj. Aliment Pharmacol Ther. 2020 Oct;52(8):1366-1376. doi: 10.1111/apt.16073. Epub 2020 Sep 9. Aliment Pharmacol Ther. 2020. PMID: 32901983 Free PMC article.
Towards a Food Pharmacy: Immunologic Modulation through Diet.
Molendijk I, van der Marel S, Maljaars PWJ. Molendijk I, et al. Among authors: maljaars pwj. Nutrients. 2019 May 31;11(6):1239. doi: 10.3390/nu11061239. Nutrients. 2019. PMID: 31159179 Free PMC article. Review.
An ileal brake-through?
Maljaars PW, Keszthelyi D, Masclee AA. Maljaars PW, et al. Am J Clin Nutr. 2010 Sep;92(3):467-8. doi: 10.3945/ajcn.2010.30180. Epub 2010 Aug 4. Am J Clin Nutr. 2010. PMID: 20685954 No abstract available.
Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn's Disease Perianal Fistulas.
Barnhoorn MC, Wasser MNJM, Roelofs H, Maljaars PWJ, Molendijk I, Bonsing BA, Oosten LEM, Dijkstra G, van der Woude CJ, Roelen DL, Zwaginga JJ, Verspaget HW, Fibbe WE, Hommes DW, Peeters KCMJ, van der Meulen-de Jong AE. Barnhoorn MC, et al. Among authors: maljaars pwj. J Crohns Colitis. 2020 Jan 1;14(1):64-70. doi: 10.1093/ecco-jcc/jjz116. J Crohns Colitis. 2020. PMID: 31197361 Free PMC article. Clinical Trial.
Anti-tumor necrosis factor therapy in patients with inflammatory bowel disease; comorbidity, not patient age, is a predictor of severe adverse events.
Asscher VER, van der Vliet Q, van der Aalst K, van der Aalst A, Brand EC, van der Meulen-de Jong AE, Oldenburg B, Pierik MJ, van Tuyl B, Mahmmod N, Maljaars PWJ, Fidder HH; Dutch ICC. Asscher VER, et al. Among authors: maljaars pwj. Int J Colorectal Dis. 2020 Dec;35(12):2331-2338. doi: 10.1007/s00384-020-03716-6. Epub 2020 Aug 28. Int J Colorectal Dis. 2020. PMID: 32860081 Free PMC article.
Ustekinumab for Crohn's Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, a Nationwide Prospective Observational Cohort Study.
Straatmijer T, Biemans VBC, Hoentjen F, de Boer NKH, Bodelier AGL, Dijkstra G, van Dop WA, Haans JJL, Jansen JM, Maljaars PWJ, van der Marel S, Oldenburg B, Ponsioen CY, Visschedijk MC, de Vries AC, West RL, van der Woude CJ, Pierik M, Duijvestein M, van der Meulen-de Jong AE. Straatmijer T, et al. Among authors: maljaars pwj. J Crohns Colitis. 2021 Apr 28:jjab081. doi: 10.1093/ecco-jcc/jjab081. Online ahead of print. J Crohns Colitis. 2021. PMID: 33909062
13 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page